Vicarious Surgical Inc. income statement RBOT

Annual Quarterly

It recorded a net loss of $10.5 million.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Q3 FY2024
Sep 30, 2024
Q2 FY2024
Jun 30, 2024
Q1 FY2024
Mar 31, 2024
Research and development
7
-15.6%
8
-26.0%
9
-17.2%
9
-5.5%
8
-0.1%
11
-17.2%
11
-14.1%
10
-25.4%
Selling, general and administrative
3
-53.1%
4
-49.5%
4
-34.2%
6
+3.1%
7
-7.9%
7
-16.3%
7
-22.4%
6
-31.5%
Operating income
-9
+38.2%
-12
+35.2%
-14
+23.7%
-16
+2.2%
-15
+3.6%
-18
+16.8%
-18
+17.5%
-16
+27.8%
Pretax income
-11
+24.5%
-11
+35.3%
-13
+13.1%
-15
+9.5%
-14
-6.2%
-17
-8.8%
-15
+0.8%
-17
+36.9%
Net income
-11
+24.5%
-11
+35.3%
-13
+13.1%
-15
+9.5%
-14
-6.2%
-17
-8.8%
-15
+0.8%
-17
+36.9%
Basic EPS
—
—
—
—
-2.36
-4.8%
-2.90
-2797.0%
-2.59
+28.5%
-0.10
+52.4%
Diluted EPS
—
—
—
—
-2.36
-4.8%
-2.90
-2797.0%
-2.59
+28.5%
-0.10
+52.4%
Weighted average shares, basic
7
+13.3%
6
+0.9%
6
+1.1%
6
+1.2%
6
+1.3%
6
+14.1%
6
+38.7%
6
-95.4%
Weighted average shares, diluted
7
+13.3%
6
+0.9%
6
+1.1%
6
+1.2%
6
+1.3%
6
+14.1%
6
+38.7%
6
-95.4%
Other measures
Depreciation and amortization
0
-46.3%
0
-30.6%
0
-23.1%
0
-29.2%
1
+3.2%
1
+13.4%
1
+21.8%
1
+18.1%
EBITDA
-9
+37.9%
-11
+35.3%
-13
+23.7%
-15
+1.3%
-14
+3.9%
-17
+17.5%
-17
+18.3%
-16
+28.7%
Interest coverage
—
—
—
—
—
—
-17,713.00x
-16,109.00x
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
RBOT (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Waltham, MA
SEC filer status
, Emerging growth company
SEC CIK
1812173
Former names
D8 Holdings Corp. (until Sep 20, 2021)

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.